ABL Bio Inc (298380) - Cash Flow Conversion Efficiency

Latest as of June 2026: -0.135x

Based on the latest financial reports, ABL Bio Inc (298380) has a cash flow conversion efficiency ratio of -0.135x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-23.42 Billion ≈ $-15.87 Million USD) by net assets (₩173.94 Billion ≈ $117.88 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 298380 market cap for the company's overall valuation and market capitalisation.

ABL Bio Inc - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how ABL Bio Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

ABL Bio Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of ABL Bio Inc ranked by their cash flow conversion efficiency. Explore 298380 cash flow quality score to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Roshow Technology Co Ltd SHE:002617	-0.024x
Azad Engineering Limited NSE:AZAD	-0.050x
Dno ASA OL:DNO	0.225x
Mayora Indah Tbk JK:MYOR	0.058x
A10 Network NYSE:ATEN	0.122x
Mobileye Global Inc. Class A Common Stock NASDAQ:MBLY	0.016x
Gujarat Mineral Development Corporation Limited NSE:GMDCLTD	0.036x
Yuan Longping High-tech Agriculture Co Ltd SHE:000998	0.151x

Annual Cash Flow Conversion Efficiency for ABL Bio Inc (2016–2025)

The table below shows the annual cash flow conversion efficiency of ABL Bio Inc from 2016 to 2025. View 298380 live share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩156.70 Billion ≈ $106.19 Million	₩-41.25 Billion ≈ $-27.96 Million	-0.263x	+36.55%
2024-12-31	₩167.28 Billion ≈ $113.36 Million	₩-69.40 Billion ≈ $-47.03 Million	-0.415x	-8.37%
2023-12-31	₩74.08 Billion ≈ $50.20 Million	₩-28.36 Billion ≈ $-19.22 Million	-0.383x	-136.90%
2022-12-31	₩69.51 Billion ≈ $47.11 Million	₩72.13 Billion ≈ $48.88 Million	1.038x	+242.99%
2021-12-31	₩55.95 Billion ≈ $37.92 Million	₩-40.61 Billion ≈ $-27.52 Million	-0.726x	-39.12%
2020-12-31	₩90.66 Billion ≈ $61.44 Million	₩-47.29 Billion ≈ $-32.05 Million	-0.522x	-188.67%
2019-12-31	₩132.01 Billion ≈ $89.46 Million	₩-23.86 Billion ≈ $-16.17 Million	-0.181x	-123.90%
2018-12-31	₩156.96 Billion ≈ $106.37 Million	₩-12.67 Billion ≈ $-8.59 Million	-0.081x	-197.13%
2017-12-31	₩-85.96 Billion ≈ $-58.25 Million	₩-7.14 Billion ≈ $-4.84 Million	0.083x	-67.72%
2016-12-31	₩-12.10 Billion ≈ $-8.20 Million	₩-3.12 Billion ≈ $-2.11 Million	0.257x	--

About ABL Bio Inc

KQ:298380 Korea Biotechnology

Market Cap

$1.94 Billion

₩2.86 Trillion KRW

Market Cap Rank

#6346 Global

#152 in Korea

Share Price

₩51100.00

Change (1 day)

-5.19%

52-Week Range

₩51100.00 - ₩245500.00

All Time High

₩245500.00